Message from the BOPA Research Committee

We are delighted to announce that we have received a record-breaking number of abstracts for the 2022 Symposium in Liverpool.  A crack team of markers are now in the process of reviewing all the abstracts and we are aiming to notify all lead authors by 2nd September if their work has been accepted.   The original abstract deadline has now closed but we will still be accepting “Late-Breaking Abstracts” (eligible for poster presentation but will not be considered for oral presentation) until Monday 8th August.  So if you have recently completed a piece of work that you would love to share, its not too late to put together and submit an abstract!

 

Submit here

Latest News

By Farah Al-sheikhli on 16th April 2026

LCC 2026 Funding Opportunity: Pharmacist Reviewers for ‘Let’s Communicate Cancer’ Programme

Let’s Communicate Cancer review 2026 The BOPA Education and Training Subcommittee have a great opportunity for pharmacists to become involved in the review of the ‘Let’s communicate cancer’ training modules.…

Read article
By Farah Al-sheikhli on 16th April 2026

NIHR INSIGHT Opening the Doors: Reimagining Inclusion in Health Research

📅 Friday 5 June 2026  🕐 12:00–16:00  📍 1 Frith Street, London W1D 3HZ ✅ Register here About this event NIHR INSIGHT South London welcomes you to join us for an afternoon dedicated…

Read article
By Joseph Williams on 15th April 2026

Thank you – and the launch of the Royal College of Pharmacy (RCPharm)

Thank you for placing your trust in me by voting me onto the English Pharmacy Advisory Council of the Royal College of Pharmacy. I am genuinely grateful for your support…

Read article
By SHBN on 8th April 2026

SHBN Webinar – Safer Handling of Hazardous Medicinal Products: Evidence, Practice and Policy Change

This session will bring together research and policy perspectives to explore the current evidence base, the practical realities faced by healthcare professionals, and the policy considerations shaping future improvements in…

Read article